Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02302261 · ClinicalTrials.gov registry record
Pleth Variability and Asthma Severity in Children
A clinical trial of Status Asthmaticus, sponsored by Northwell Health.
- Completed
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT02302261: Completed study of Status Asthmaticus, sponsored by Northwell Health.
NCT02302261 is a study of Status Asthmaticus that has completed, run by Northwell Health. The registered enrollment target is 37 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02302261, a study of Status Asthmaticus, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
Research has shown that pleth variability can be used to assess asthma severity in children with status asthmaticus. The investigators would like to use an FDA-cleared monitor (Masimo Radical 7) which measures Pleth Variability Index (PVI) to see if the degree of PVI can be used to help triage patients who present to the pediatric ED in status asthmaticus.
Primary Outcome
Determine whether a patient was discharged from the ED, admitted to an inpatient floor or admitted to the ICU.
Conditions Studied
Study Locations (1)
New York
- Cohen Children's Medical Center of NY - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-07 |
What the finished NCT02302261 record still lists
NCT02302261 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 1 condition, with Status Asthmaticus appearing as the primary indexed condition, and to 0 interventions.
NCT02302261 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02302261 about?
NCT02302261 is a clinical study titled "Pleth Variability and Asthma Severity in Children". Research has shown that pleth variability can be used to assess asthma severity in children with status asthmaticus. The investigators would like to use an FDA-cleared monitor (Masimo Radical 7) which measures Pleth Variability Index (PVI) to see if the degree of PVI can be used to help triage patie...
What is the current status of trial NCT02302261?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2015-01. Estimated completion is 2016-07.
What conditions does trial NCT02302261 study?
This clinical trial studies the following conditions: Status Asthmaticus.
Who is sponsoring clinical trial NCT02302261?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02302261 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Asthmaticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia